Skip to main content

Table 4 ART related adverse events experienced by patients and proportions that had adverse events in patients that were LTFU versus those still in care, Tshepang Pharmacovigilance cohort, 2004-2012

From: Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004–2012: a cohort study

Adverse event

Total

LTFU

In Care

 

N

%

n

(%)

n

%

Peripheral Neuropathy

165

52.2

39

28.1

126

21.2

Lipodystrophy

121

38.3

11

7.2

110

24.1

Hyperlactateaemia

83

26.3

13

9.4

70

15.4

*Others

19

6.0

6

4.3

13

2.9

  1. *Others include anaemia, various dermatological adverse events, Central nervous system adverse events, diarrhoea and vomiting, lipid abnormalities and hepatititis